Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series

Código QR

Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series

Leszek Bidzan,1 Mariola Bidzan2 1Department of Developmental Psychiatry, Psychotic and Geriatric Disorders, Medical University of Gdansk, Gdansk, Poland; 2Institute of Psychology, University of Gdansk, Gdansk, PolandCorrespondence: Mariola Bidzan Email mariola.bidzan@ug.edu.plAbstract: Sleep disorde...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bidzan L, Bidzan M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	sleep disorders alzheimer's disease treatment methylphenidate Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/dbf1584f61dd4dd1995323ec09b232ec
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment
por: Masi G, et al.
Publicado: (2019)

Excessive Daytime Sleepiness and Cardiovascular Mortality in US Adults: A NHANES 2005–2008 Follow-Up Study
por: Li J, et al.
Publicado: (2021)

Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients
por: Talih FR, et al.
Publicado: (2017)

Case Report: Insulinoma Presenting as Excessive Daytime Somnolence
por: Zhennan Yu, et al.
Publicado: (2021)

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
por: Huss M, et al.
Publicado: (2017)

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
por: Zhang N, et al.
Publicado: (2018)

Clinical Characteristics, Iron Metabolism and Neuroinflammation: New Insight into Excessive Daytime Sleepiness in Parkinson’s Disease
por: Hu Y, et al.
Publicado: (2021)

Changes in behavior as side effects in methylphenidate treatment: review of the literature
por: Konrad-Bindl DS, et al.
Publicado: (2016)

The Moderating Effects of Personal Resources on Caregiver Burden in Carers of Alzheimer's Patients
por: Anna Sołtys, et al.
Publicado: (2021)

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness
por: Omori Y, et al.
Publicado: (2018)

Occupational Outcomes Associated with Sleep Quality and Excessive Daytime Sleepiness: Results from a National Survey
por: AlShareef SM
Publicado: (2020)

Decreased Risk of Influenza in Child and Adolescent Patients with Attention-Deficit Hyperactivity Disorder Following Methylphenidate Treatment: A Nationwide Cohort Study in Taiwan
por: Lee H, et al.
Publicado: (2020)

Tailored lighting intervention improves measures of sleep, depression, and agitation in persons with Alzheimer’s disease and related dementia living in long-term care facilities
por: Figueiro MG, et al.
Publicado: (2014)

Six months methylphenidate treatment improves emotion dysregulation in adolescents with attention deficit/hyperactivity disorder: a prospective study
por: Suzer Gamli I, et al.
Publicado: (2018)

Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility
por: Guevarra JT, et al.
Publicado: (2020)

Association between Free Sugars Intake and Excessive Daytime Sleepiness among Chinese Adolescents
por: Yue Xi, et al.
Publicado: (2021)

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease
por: Yoshiyuki Kagawa, et al.
Publicado: (2021)

Patterns of Response to Methylphenidate Administration in Children with ADHD: A Personalized Medicine Approach through Clustering Analysis
por: Silvia Grazioli, et al.
Publicado: (2021)

Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies
por: Urrestarazu E, et al.
Publicado: (2016)

Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives
por: Abad VC
Publicado: (2021)

Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease
por: Aydin EY, et al.
Publicado: (2020)

Are psychiatric comorbidities and associated cognitive functions related to treatment response to methylphenidate in boys with attention-deficit/hyperactivity disorder?
por: Chan MH, et al.
Publicado: (2017)

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
por: Omori Y, et al.
Publicado: (2018)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Stuart J Thomas, et al.
Publicado: (2009)

Inspiratory Muscle Training in the Severity of Obstructive Sleep Apnea, Sleep Quality and Excessive Daytime Sleepiness: A Placebo-Controlled, Randomized Trial
por: Nóbrega-Júnior JCN, et al.
Publicado: (2020)

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
por: Huss M, et al.
Publicado: (2016)

International journal of Alzheimer's disease

Daytime sleepiness in elderly Parkinson&rsquo;s disease patients and treatment with the psychostimulant modafinil: A preliminary study
por: Johan L&ouml;kk
Publicado: (2010)

Adherence to a Dietary Approach to Stop Hypertension (DASH)-Style in Relation to Daytime Sleepiness
por: Pahlavani N, et al.
Publicado: (2020)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Observation and Interview-based Diurnal Sleepiness Inventory for measurement of sleepiness in older adults
por: Pak VM, et al.
Publicado: (2017)

Detecting Excessive Daytime Sleepiness With CNN And Commercial Grade EEG
por: I Putu Agus Eka Darma Udayana, et al.
Publicado: (2021)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan J, et al.
Publicado: (2013)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
por: Klimova B, et al.
Publicado: (2017)

Olfactory dysfunction in Alzheimer’s disease
por: Zou YM, et al.
Publicado: (2016)

Sleep, eating disorder symptoms, and daytime functioning
por: Tromp MD, et al.
Publicado: (2016)

Reeducación psicomotriz en personas con enfermedad de Alzheimer
por: Serdà I Ferrer,Bernat-Carles, et al.
Publicado: (2013)

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
por: Muratli S, et al.
Publicado: (2015)

Alzheimer's research & therapy
Publicado: (2009)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017)